...
首页> 外文期刊>Annals of Surgery >Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.
【24h】

Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.

机译:胆胰转移对BMI 25至35的2型糖尿病的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Biliopancreatic diversion (BPD) resolves type 2 diabetes in near totality of morbidly obeses [BMI (body mass index) >/=35 kg/m]. However, studies of BPD effect in BMI range 25.0 to 34.9 kg/m, including about 90% of diabetic patients, are lacking. MATERIALS AND METHODS: If BPD effects are independent of weight changes, they should be maintained in patients who, being mildly obese or overweight, will lose little or no weight after operation. Thirty type 2 diabetic patients with BMI 25 to 34.9 were submitted to BPD and monitored 12 months. Thirty-eight diabetic patients selected from a large database, kept 1 year on medical therapy, served as controls. RESULTS: Nineteen male and 11 female. Mean age 56.4 +/- 7.4 years, weight 84.8 +/- 11.1 kg, BMI 30.6 +/- 2.9 kg/m, waist circumference 104 +/- 9.4 cm, diabetes duration 11.2 +/- 6.9 years, HbA1c 9.3+/-1.5. Twelve patients on insulin. Fifteen (2 F) with BMI < 30 (mean: 28.1). No mortality or major adverse events occurred. BMI progressively decreased, stabilizing around 25 since the fourth month, without excessive weight loss. One year after BPD, mean HbA1c was 6.3%+/-0.8, with 25 patients (83%) controlled (HbA1c
机译:目的:胆胰转移(BPD)可解决几乎全部病态肥胖[BMI(体重指数)> / = 35 kg / m]的2型糖尿病。但是,尚无关于BMI在25.0至34.9 kg / m 2范围内的BPD效果的研究,包括约90%的糖尿病患者。材料和方法:如果BPD的作用与体重的变化无关,则应在轻度肥胖或超重且术后体重减轻或没有体重减轻的患者中保持这种作用。 30例BMI 25至34.9的2型糖尿病患者接受了BPD监测12个月。从一个大型数据库中选择了38名糖尿病患者作为对照,他们接受了1年的药物治疗。结果:男19例,女11例。平均年龄56.4 +/- 7.4岁,体重84.8 +/- 11.1 kg,BMI 30.6 +/- 2.9 kg / m,腰围104 +/- 9.4 cm,糖尿病持续时间11.2 +/- 6.9年,HbA1c 9.3 +/- 1.5。十二名患者接受胰岛素治疗。 BMI <30(平均:28.1)的十五(2 F)。没有发生死亡或重大不良事件。体重指数逐渐下降,自第四个月以来一直稳定在25左右,且体重没有过多减轻。 BPD一年后,平均HbA1c为6.3%+ /-0.8,其中25例患者(83%)接受了免费饮食控制(HbA1c == 7%),无抗糖尿病药,其余患者均得到改善。急性胰岛素对静脉葡萄糖的反应从1.2 +/- 2.9增加到4.2 +/- 4.4 muIU / mL。糖尿病的消退与BMI呈正相关。对照组中的HbA1c在第1年下降,并且抗糖尿病治疗的总量增加。结论:BPD可改善或解决BMI 25至35中的糖尿病,而不会引起体重过多减轻,其作用是对胰岛素敏感性和β细胞功能的影响。病态肥胖和低BMI患者之间显着不同的反应可能取决于不同的β细胞缺陷。 ClinicalTrials.gov标识符:NCT00996294。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号